L.O. Badalyan and current progress in the study of hereditary neuromuscular diseases

Cover Page

Abstract


Hereditary neuromuscular diseases (HNMD) represent a large group of heterogenic morbid conditions, characterized by muscular weakness, muscular atrophies, disturbances of postural control and locomotor functions. Scientific research on HNMD, performed by academician L.O. Badalyan and his followers laid the background for solving many issues, regarding the diagnosis and treatment of these severe, progressive diseases. In many ways, academician L.O. Badalyan and his followers have anticipated the current understanding of pathogenic mechanisms of HNMD, which later were disclosed by means of modern molecular-genetic technologies. HNMD include progressive muscular dystrophies (PMD), spinal muscular atrophies (SMA), hereditary motor and sensory neuropathies, myopathic syndromes. The most prevalent progressive HNMDs are represented by dystrophinopathies (Duchenne PMD and Becker PMD) and limb girdle HNMD. The authors discuss experience and achievements in the studies of HNMDs and PMDs, conducted by academician L.O. Badalyan and his followers, as necessary prerequisites for the creation of modern approaches to genetic diagnostics of the diseases and forming their genetic registries, development of methods of etiopathogenetic therapy. Thanks to the accumulated experience and research there were discovered genes, which determine the HNMD development, pathogenic mechanisms of diseases with heterogenic clinical manifestations were studied. The data were accumulated for the formation of patients’ registries, determining groups for which a particular drug is being developed. The progress in genetic research has made it possible to identify more than 30 forms of limb-girdle PMD. A newly published classification of limb-girdle PMD is given, illustrating their genetic heterogeneity, the type of inheritance, the genetic locus of the mutation and defective protein are now taken into account. The article lists promising current global trends in the development of approaches to pathogenetic therapy of dystrophinopathies and limb-girdle PMD.


Full Text

Restricted Access

About the authors

Nikolay N. Zavadenko

N.I. Pirogov Russian National Research Medical University

Author for correspondence.
Email: zavadenko@mail.ru

Russian Federation, Moscow

Dmitry V. Vlodavets

N.I. Pirogov Russian National Research Medical University; Academician Yu. E. Veltischev Research and Clinical Institute for Pediatrics of the N.I. Pirogov Russian National Research Medical University

Email: zavadenko@mail.ru

Russian Federation, Moscow

References

  1. Badalyan L.O. Lectures on Clinical Genetics [Lektsii po klinicheskoy genetike]. Moscow; 1974. (in Russian)
  2. Badalyan L.O., ed. Hereditary Neuromuscular Diseases. Progressive Muscular Dystrophies [Nasledstvennye bolezni nervno-myshechnoy sistemy. Progressiruyushchie myshechnye distrofii]. Moscow; 1974. (in Russian)
  3. Badalyan L.O., Skvortsov I.A. Clinical Electroneuromyography [Klinicheskaya elektroneyromiografiya]. Moscow: Meditsina; 1986. (in Russian)
  4. Badalyan L.O. The Problems of Developmental Neurology. Assembly Speech [Problemy evolyutsionnoy nevrologii. Aktovaya rech’]. Moscow; 1981. (in Russian)
  5. Moat S.J., Bradley D.M., Salmon R., Clarke A., Hartley L. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). Eur. J. Hum. Genet. 2013; 21(10): 1049-53. DOI: http://doi.org/10.1038/ejhg.2012.301
  6. Mah J.K., Korngut L., Dykeman J., Day L., Pringsheim T., Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul. Disord. 2014; 24(6): 482-91. DOI: http://doi.org/10.1016/j.nmd.2014.03.008
  7. Romitti P.A., Zhu Y., Puzhankara S., James K.A., Nabukera S.K., Zamba G.K., et al. Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics. 2015; 135(3): 513-21. DOI: http://doi.org/10.1542/peds.2014-2044
  8. Badalyan L.O., Temin P.A., Zavadenko N.N., Kamennykh L.N., Nikanorova M.Yu. Clinical polymorphism of the progressive Duchenne muscular dystrophy. Pediatriya. Zhurnal im. G.N. Speranskogo. 1987; 87(12): 40-3. (in Russian)
  9. Temin P.A., Zavadenko N.N., Kamennykh L.N., Nikanorova M.Yu. Diagnostic features of the progressive Duchenne muscular dystrophy. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1989; 89(3): 93-6. (in Russian)
  10. Badalyan L.O., Arkhipov B.A., Temin P.A., Zavadenko N.N., Voloshina T.G. Pseudohypertrophic forms of progressive muscular dystrophies with the puberty onset and malignant course of myodystropic process. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1988; 88(3): 61-4. (in Russian)
  11. Badalyan L.O., Temin P.A., Saidbegov D.G., Nikitin M.V., Arkhipov B.A., Zavadenko N.N., et al. Pseudohypertrophic proximal progressive muscular dystrophy with the puberty onset and malignant course. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1989; 89(3): 113-20. (in Russian)
  12. Badalyan L.O., Temin P.A., Arkhipov B.A., Zavadenko N.N., Bobrova K.F., Lysov V.L. Family cases of atypical pseudohypertrophic proximal progressive muscular dystrophy. Sovetskaya meditsina. 1989; 52(9): 96-100. (in Russian)
  13. Badalyan L.O., Temin P.A., Arkhipov B.A., Zavadenko N.N. Genetic registry and clinical examination of patients with progressive Duchenne muscular dystrophy. Voprosy okhrany materinstva i detstva. 1988; 33(10): 33-9. (in Russian)
  14. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987; 51(6): 919-28. DOI: http://doi.org/10.1016/0092-8674(87)90579-4
  15. Koenig M., Monaco A.P., Kunkel L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988; 53(2): 219-28. DOI: http://doi.org/10.1016/0092-8674(88)90383-2
  16. Chukhrova A.L., Malygina N.A., Polyakov A.V., Zaytseva S.P., Sitnikov V.F., Dadali E.L., et al. Deletions screening in patients with Duchenne muscular dystrophy using the method of polymerase chain reaction. Tsitologiya i genetika. 1994; 28(4): 80-4. (in Russian)
  17. Zotova E.D., Reshetov D.A., Zhernovkov V.E., Vlodavets D.V., Dimitrieva T.V., Deykin A.V. Analysis of phenotype expressions of deletions in the dystrophin gene in terms of efficiency of exon skipping as a method for treatment of hereditary dystrophinopathies. Vestnik RGMU. 2016; (3): 23-9. (in Russian)
  18. Aartsma-Rus A., Ginjaar I.B., Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J. Med. Genet. 2016; 53(3): 145-51. DOI: http://doi.org/10.1136/jmedgenet-2015-103387
  19. Badalyan L.O., Temin P.A., Zavadenko N.N., Voloshina T.G., Krylova L.N., Lysov V.L. Autosomal-recessive form of pseudohypertrophic progressive muscular dystrophy in children. Voprosy okhrany materinstva i detstva. 1990; 35(4): 72-5. (in Russian)
  20. Badalyan L.O., Temin P.A., Kalinin V.A., Arkhipov B.A., Zavadenko N.N., Voloshina T.G., et al. Proximal muscular dystrophy with contractures and malignant course – the variant of Emery-Dreifuss disease? Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1990; 90(3): 52-6. (in Russian)
  21. Straub V., Murphya A., Udd B. 229th ENMC international workshop: Limb girdle muscular dystrophies – nomenclature and reformed classification. Neuromuscul. Disord. 2018; 28(8): 702-10. DOI: http://doi.org/10.1016/j.nmd.2018.05.007
  22. Vlodavets D.V., Reshetov D.A., Artemieva S.B., Shulyakova I.V., Shidlovskaya O.A., Monakhova A.V., et al. DMD genetic registry in Russia. Neuromuscul. Disord. 2017; 27(Suppl. 2): S128-9. DOI: http://doi.org/10.1016/j.nmd.2017.06.135
  23. Vlodavets D.V., Reshetov D.A., Monakhova A.V., Artemieva S.B., Shulyakova I.V., Shidlovskaya O.A., et al. Neuromuscular genetic registry in Russia. Neuromuscul. Disord. 2018; 5(Suppl. 1): S320-1. DOI: http://doi.org/10.3233/JND-189001
  24. Vlodavets D., Monakhova A., Shidlovskaya O., Shulyakova I., Artemieva S., Melnik E., et al. New advances in the Neuromuscular Diseases Registry in Russia. Neuromuscul. Disord. 2019; 29(Suppl. 1): S196. DOI: http://doi.org/10.1016/j.nmd.2019.06.555
  25. Chamberlain J.R., Chamberlain J.S. Progress toward gene therapy for Duchenne muscular dystrophy. Mol. Ther. 2017; 25(5): 1125-31. DOI: http://doi.org/10.1016/j.ymthe.2017.02.019
  26. Guiraud S., Davies K.E. Pharmacological advances for treatment in Duchenne muscular dystrophy. Curr. Opin. Pharmacol. 2017; 34: 36-48. DOI: http://doi.org/10.1016/j.coph.2017.04.002
  27. Davies K.E., Chamberlain J.S. Surrogate gene therapy for muscular dystrophy. Nat. Med. 2019; 25(10): 1473-4.
  28. Vlodavets D., Servais L., Baranello G., Day J.W., Deconinck N., Mercuri E., et al. FIREFISH Part 1: Survival, ventilation and swallowing ability in infants with Type 1 spinal muscular atrophy (SMA) treated with risdiplam (RG7916). Eur. J. Neurol. 2019; 26(Suppl. 1): 310-1.
  29. Peters T., Jevtic S., Carr D., Kieloch A., Valentin M.A., Dobrzycka-Ambrozevicz A., et al. Serum Neurofilament Light Chain in Type 1 Spinal Muscular Atrophy: Second Part of a Branaplam Phase II Study. Neuromuscul. Disord. 2019; 29(Suppl. 1): S147. DOI: http://doi.org/10.1016/j.nmd.2019.06.387

Statistics

Views

Abstract - 73

PDF (Russian) - 1

Cited-By


Refbacks

  • There are currently no refbacks.

Copyright (c) 2020 Zavadenko N.N., Vlodavets D.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies